Medpace executed a case study on Duchenne Muscular Dystrophy clinical trials, highlighting how Medpace executes DMD trials seamlessly.
Published
Signal category
Research & Knowledge
Quote
“Explore this case study to explore how Medpace executes #DMD trials seamlessly”
— Medpace team
Company
Medpace
Accelerating Drug, Biologic and Medical Device Clinical Development
- Industry
- Pharmaceutical Manufacturing
- Location
- Cincinnati, US
- Company size
- 6,610 employees
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries.
Founded 1992